IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 217 filers reported holding IMMUNOGEN INC in Q2 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $13,000 | +1200.0% | 1,813 | +602.7% | 0.00% | – |
| Q3 2021 | $1,000 | -50.0% | 258 | +11.2% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 232 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 232 | -16.8% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 279 | -26.2% | 0.00% | – |
| Q3 2020 | $1,000 | -66.7% | 378 | -50.3% | 0.00% | – |
| Q1 2020 | $3,000 | 0.0% | 760 | +34.0% | 0.00% | – |
| Q4 2019 | $3,000 | +200.0% | 567 | +15.5% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 491 | +105.4% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 239 | -20.6% | 0.00% | – |
| Q1 2019 | $1,000 | – | 301 | +3244.4% | 0.00% | – |
| Q3 2018 | $0 | – | 9 | -35.7% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 14 | -98.6% | 0.00% | – |
| Q4 2016 | $2,000,000 | +66566.7% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $3,000 | – | 1,000 | – | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q3 2014 | $32,000 | – | 3,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,984,734 | $15,421,000 | 1.00% |
| Moloney Securities Asset Management, LLC | 274,450 | $1,062,000 | 0.55% |
| Schonfeld Strategic Advisors LLC | 1,025,176 | $3,968,000 | 0.40% |
| Orbimed Advisors | 6,095,647 | $23,590,000 | 0.27% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $438,000 | 0.26% |
| PINNACLE ASSOCIATES LTD | 1,589,959 | $6,153,000 | 0.12% |
| Baker Brothers Advisors | 3,015,353 | $11,669,000 | 0.10% |
| BAXTER BROS INC | 58,000 | $224,000 | 0.07% |
| SIMON QUICK ADVISORS, LLC | 25,000 | $97,000 | 0.06% |
| ClearBridge Investments | 14,428,856 | $55,840,000 | 0.06% |